Clover Health Investments (NasdaqGS:CLOV) Q4 2025 Earnings call February 26, 2026 05:00 PM ET Company ParticipantsAndrew Toy - CEOJohn Pinney - Senior Equity Research AssociatePeter Kuipers - CFONone - Company RepresentativeConference Call ParticipantsJonathan Yong - Executive Director, Equity Research AnalystOperatorHello, and welcome to Clover Health's fourth quarter 2025 earnings call. We ask that you please hold all questions until the completion of the formal remarks, at which time you will be given in ...

Clover Health Investments (NasdaqGS:CLOV) Q4 2025 Earnings call February 26, 2026 05:00 PM ET Speaker3Hello, and welcome to Clover Health's fourth quarter 2025 earnings call. We ask that you please hold all questions until the completion of the formal remarks, at which time you will be given instructions for the question and answer session. As a reminder, this conference is being recorded today. If you have any objections, please disconnect at this time. Ryan, you may begin.Speaker5Good afternoon, everyone. ...

Accounting (#s Fourth Quarter & Full Year 2025 Earnings Conference Call February 26, 2026 LGTMs: Date: Andrew T. (Input) 2/24 (via Jessie) Peter K. 2/24 Karen S. (Legal) 2/24/26 confirm) LGTM 2.24.26 Disclaimer This presentation and the accompanying oral presentation include forward-looking statements, including, without limitation, statements regarding future events and Clover Health Investments, Corp.'s ("Clover Health," "we," "our," or "us") expectations regarding GAAP Net Income, Adjusted EBITDA, Adjust ...

Exhibit 99.1 Clover Health Reports Fourth Quarter & Full Year 2025 Results; Provides Full Year 2026 Guidance Business Highlights: Financial Results: Full Year 2026 Guidance: WILMINGTON, Del. – February 26, 2026 – Clover Health Investments, Corp. (Nasdaq: CLOV) ("Clover," "Clover Health" or the "Company"), today reported financial results for the fourth quarter and full year 2025. Management will host a conference call today at 5:00 p.m. ET to discuss its operating results and other business highlights. "Our ...

Business Highlights: Generated full year 2025 Adjusted EBITDA profitability while growing membership by 38% and Insurance revenue by 41% year-over-yearAchieved industry-leading 2026 AEP growth of 53% year-over-year with strong returning member retentionExpect improving cohort economics powered by Clover Assistant to drive our first-ever full year of GAAP Net Income profitability in 2026 Financial Results: Full year 2025 Medicare Advantage membership of 113,803, up 38% year-over-yearFull year 2025 Total reve ...

WILMINGTON, Del., Feb. 17, 2026 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that its Chief Financial Officer, Peter Kuipers, will present at the Leerink 2026 Global Healthcare Conference on Tuesday, March 10, 2026, at 9:20 a.m. Eastern Time. A live webcast and replay of the presentation and Q&A session will be accessible on Clover Health's investor relations website at https://investors.cloverhealth.com/. About Clover Heal ...

Core Insights - Clover Health Investments, Corp. is recognized as one of Goldman Sachs' top penny stock picks, with a scheduled release of fourth-quarter financial results on February 26, 2026 [1] Group 1: Membership Growth - The company reported a 53% increase in enrollees in its Medicare Advantage Plans for the 2026 plan year, starting with approximately 153,000 members as of January 1, 2026 [2] - Over 97% of its Medicare Advantage membership is enrolled in the flagship app PPO plan, with growth concentrated in core markets supported by the Clover Assistant platform and home care offerings [2] Group 2: Path to Profitability - Clover Health is on track to achieve its first-ever GAAP net income, driven by cost optimization and favorable industry-specific factors [3] - The CEO indicated that these dynamics are expected to lead to compounding earnings and margin expansion, positioning Clover for its first year of GAAP net income profitability in 2026 [3] Group 3: Company Overview - Clover Health is a healthcare technology company focused on enhancing medical outcomes for seniors through Medicare Advantage plans and its proprietary software platform, Clover Assistant [4] - The company operates as a next-generation insurer, providing PPO and HMO plans to Medicare beneficiaries [4]

Core Insights - The meme stock phenomenon began in 2021 with GameStop, driven by retail traders on Reddit's WallStreetBets forum, leading to significant price surges due to short squeezes [1] - Investments in meme stocks from 2016 or at their IPOs have resulted in varied outcomes, with some stocks yielding massive gains while others have led to substantial losses [2] Investment Performance - A $1,000 investment in various meme stocks a decade ago would yield different values today, highlighting the volatility and potential of these stocks [3] - Notable performance includes: - GameStop (GME): $3,532 (+253%) - AMC Entertainment Holdings (AMC): $11 (-98.9%) - Palantir Technologies (PLTR): $14,659 (+1,366%) - Carvana (CVNA): $29,712 (+2,871%) - Roku (ROKU): $6,033 (+503%) [4] Market Trends - Meme stocks continue to emerge, indicating a persistent trend driven by social media sentiment rather than traditional business fundamentals [5]

Core Viewpoint - Clover Health Investments, Corp. is set to release its financial results for the fourth quarter and full year of 2025 on February 26, 2026, with a management webcast to follow discussing business and financial performance [1]. Group 1: Financial Results Announcement - The financial results will be announced after market close on February 26, 2026 [1]. - A webcast presentation by the company's management will take place at 5:00 p.m. Eastern Time on the same day [1][4]. Group 2: Webcast Details - A live and archived version of the conference call will be available on Clover Health's Investor Relations website for 12 months [2]. - Registration for the webcast can be done through a specific link provided [4]. Group 3: Company Overview - Clover Health is a physician enablement technology company focused on improving healthcare access for Medicare recipients, particularly seniors [3]. - The company utilizes its software platform, Clover Assistant, to aggregate patient data and enhance clinical decision-making, aiming to improve health outcomes [3]. - Clover Health offers PPO and HMO Medicare Advantage plans and extends its technology benefits through its subsidiary, Counterpart Health, to improve patient outcomes and reduce healthcare costs [3].

Core Viewpoint - Clover Health Investments (CLOV) has seen a significant price decline of nearly 23%, currently trading at $2.49, despite a previous spike of 53% [1] Company Analysis - The analysis emphasizes a disciplined approach to evaluating companies, focusing on financial metrics and business fundamentals rather than market narratives [1] - The current situation of Clover Health suggests a cautious stance, indicating that it remains a "wait-and-see" investment opportunity [1]